| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.14B | 5.72B | 6.79B | 6.53B | 4.74B |
| Gross Profit | 964.95M | 1.28B | 1.65B | 1.53B | 1.24B |
| EBITDA | 922.30M | 1.01B | 1.48B | 1.41B | 1.20B |
| Net Income | 62.80M | 278.88M | 647.73M | 737.69M | 650.91M |
Balance Sheet | |||||
| Total Assets | 10.30B | 10.07B | 11.06B | 9.20B | 6.13B |
| Cash, Cash Equivalents and Short-Term Investments | 88.67M | 75.97M | 126.50M | 127.02M | 68.91M |
| Total Debt | 4.16B | 4.26B | 4.64B | 3.58B | 1.62B |
| Total Liabilities | 5.49B | 5.61B | 6.37B | 5.31B | 2.79B |
| Stockholders Equity | 4.74B | 4.38B | 4.61B | 3.81B | 3.28B |
Cash Flow | |||||
| Free Cash Flow | 679.23M | 506.81M | 342.26M | 420.94M | 430.02M |
| Operating Cash Flow | 1.06B | 839.29M | 899.26M | 813.74M | 704.42M |
| Investing Cash Flow | -720.28M | -498.90M | -1.68B | -2.42B | -490.26M |
| Financing Cash Flow | -337.89M | -399.56M | 876.29M | 1.68B | -221.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $8.87B | 8.73 | 30.72% | ― | 1.81% | 24.67% | |
74 Outperform | $7.12B | 9.71 | 17.25% | 2.86% | -3.83% | -2.04% | |
65 Neutral | $5.68B | 31.72 | 22.69% | 3.37% | 2.35% | 9.61% | |
64 Neutral | $9.03B | 94.10 | 1.36% | ― | -0.83% | -58.55% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | $2.17B | 18.24 | -47.89% | ― | 16.05% | -10.17% |
On February 25, 2026, Darling Ingredients announced that long-time director Gary W. Mize plans to retire from its board at the company’s 2026 Annual Meeting of Stockholders, where he will step down as Lead Director and Chairman of the Nominating and Corporate Governance Committee after a decade of service that helped drive the company’s global agribusiness expansion. The same day, the board elected retired Cargill executive Robert Aspell as an independent director and Audit Committee member, expanding the board to 11 seats and adding deep international agribusiness, supply chain and M&A experience that is expected to strengthen strategic oversight and support Darling’s growth ambitions and shareholder value focus.
Mr. Aspell will receive standard non-employee director compensation, including cash retainers and restricted stock units, and enter into the company’s customary indemnification agreement, underscoring that his appointment follows standard governance practices. Darling’s leadership highlighted that the transition balances continuity with fresh global expertise, signaling continued emphasis on risk management, international expansion and disciplined governance as the company advances its position in the global food, agriculture and renewable energy value chains.
The most recent analyst rating on (DAR) stock is a Buy with a $61.00 price target. To see the full list of analyst forecasts on Darling Ingredients stock, see the DAR Stock Forecast page.
On December 10, 2025, Darling Ingredients Inc. announced a definitive agreement with Tessenderlo Group to form a joint venture, combining their collagen and gelatin business segments into a new company, NewCo Collagen LLC. Darling will hold an 85% stake, while Tessenderlo will hold 15%, with expected annual revenue of $1.5 billion. The venture aims to capitalize on the growing collagen market, leveraging synergies and expanding the Nextida product portfolio. The transaction, pending regulatory approvals, is expected to close in 2026, enhancing growth opportunities and shareholder value for Darling Ingredients.
The most recent analyst rating on (DAR) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Darling Ingredients stock, see the DAR Stock Forecast page.